Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix Inc

OCULNASDAQ

$10.49

-0.13-1.22%

近くで: Sep 11, 5:00 PM EST

$10.69

0.201.91%

時間外: Sep 11, 7:44 PM EST

Ocular Therapeutix (OCUL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.7% of shares outstanding. Institutional investors hold 46.6%. Over the past 90 days, insiders made 5 sales worth $333K.

Shares Outstanding

219.616M

Shares Float

186.085M

Insider Shares Owned

8.192M

Insider % Owned

3.7%

Institutional Shares Held

102.439M

Institutional % Held

46.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$333K total

Net Activity

Net Selling

Net Value (90d)

-$333K

Date	Insider	Title	Type	Shares	Price	Value
Aug 31, 2026	Donald Notman	CHIEF OPERATING OFFICER	SELL	1.099K	$10.24	$11K
Aug 24, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	3.035K	$10.77	$33K
Aug 24, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.897K	$10.78	$20K
Aug 24, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.296K	$10.78	$36K
Aug 24, 2026	Pravin Dugel	SEE REMARKS	SELL	21.649K	$10.77	$233K
Jun 3, 2026	Nadia Waheed	CHIEF MEDICAL OFFICER	SELL	14.828K	$8.27	$123K
May 26, 2026	Pravin Dugel	SEE REMARKS	SELL	21.156K	$8.20	$173K
May 26, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	2.967K	$8.20	$24K
May 26, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.018K	$8.20	$25K
May 26, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.858K	$8.20	$15K